The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

The following is a summary of "Adherence and persistence among people with type 2 diabetes newly initiating oral semaglutide ...

New research finds that semaglutide medications like Ozempic and Wegovy may help to lower the risk of alcohol-related issues.

For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications.

A new study published in JAMA Psychiatry linked GLP-1 receptor agonists like Ozempic with a lower risk of alcohol-related ...

GLP-1RA prescription trends, real-world effectiveness, and predictors for access and rationing were highlighted at ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

The weight-loss jab Wegovy made its debut on June 4 2021 . It was the first new weight-loss drug to be approved by the US ...

Nicole Wright, from North Ayrshire, Scotland, wanted to lose weight before an upcoming vacation to Turkey. In August she ...

Pharma and biotech stocks are down due to concerns over Robert F. Kennedy Jr. possibly taking the helm at HHS. Read more here ...

A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.

Researchers said the analysis lays bare a ‘decades-long-failure’ to tackle the overweight and obesity epidemic ...